Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy.

Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy.
复制标题

DOI:
10.3389/fonc.2018.00107
复制
发表时间:
2018
影响因子:
4.7
通讯作者:
Menter DG
Menter DG
中科院分区:
医学3区
文献类型:
--
作者:
Kanikarla-Marie P;Lam M;Sorokin AV;Overman MJ;Kopetz S;Menter DG

文献摘要

参考文献

被引文献

相似文献

血小板在癌症进展中的作用在癌症生物学领域已得到广泛认可。新兴的研究正在进一步阐述血小板在促进肿瘤发生中的额外作用和增加的程度。血小板释放支持肿瘤生长的因子,也与肿瘤细胞形成异型聚集体,这可以提供免疫逃避优势。它们最关键的作用可能是抑制免疫细胞功能,这可能对身体预防肿瘤建立和生长的能力产生负面影响。这篇综述总结了血小板在肿瘤进展、治疗反应、生存率中的重要性,最后总结了免疫治疗调制可能受益于血小板抑制剂的概念。
The role of platelets in cancer progression has been well recognized in the field of cancer biology. Emerging studies are elaborating further the additional roles and added extent that platelets play in promoting tumorigenesis. Platelets release factors that support tumor growth and also form heterotypic aggregates with tumor cells, which can provide an immune-evasive advantage. Their most critical role may be the inhibition of immune cell function that can negatively impact the body’s ability in preventing tumor establishment and growth. This review summarizes the importance of platelets in tumor progression, therapeutic response, survival, and finally the notion of immunotherapy modulation being likely to benefit from the inclusion of platelet inhibitors.
DOI: 10.1093/carcin/bgs204
发表时间: 2012-09-01
期刊: CARCINOGENESIS
影响因子: 4.7
作者:
Alder, Hansjuerg;Taccioli, Cristian;Fong, Louise Y. Y.
通讯作者: Fong, Louise Y. Y.
DOI: 10.7326/m15-2129
发表时间: 2016-06-21
影响因子: 39.2
作者:
Dehmer, Steven P.;Maciosek, Michael V.;Whitlock, Evelyn P.
通讯作者: Whitlock, Evelyn P.
血小板对卵巢癌的影响。
DOI: 10.1053/j.seminoncol.2014.04.004
发表时间: 2014-06
影响因子: 4
作者:
Davis AN;Afshar-Kharghan V;Sood AK
通讯作者: Sood AK
DOI: 10.1186/s12885-015-1634-x
发表时间: 2015-09-09
期刊: BMC cancer
影响因子: 3.8
作者:
Cooke NM;Spillane CD;Sheils O;O'Leary J;Kenny D
通讯作者: Kenny D
DOI: 10.1038/sj.bjp.0705606
发表时间: 2004-01-01
影响因子: 7.3
作者:
Alonso-Escolano, D;Strongin, AY;Radomski, MW
通讯作者: Radomski, MW